Feature

Q&A: Updates on COVID-19 protocols in primary care

March 26, 2020
Health care providers across the world are adjusting to the challenges of caring for patients during the global COVID-19 pandemic. Healio…
Perspective

AACE statement offers COVID-19 guidance for people with adrenal insufficiency, Cushing’s syndrome

March 26, 2020
People with adrenal insufficiency or uncontrolled Cushing’s syndrome are at greater risk for death from a respiratory-related infection, such…
Commentary

Out of aces: Kenny Rogers, oncology and the novel coronavirus

March 26, 2020
By Rujuta Saksena, MD After learning that Kenny Rogers died this past weekend, my mind started to link the parallels between his lyrics to…
Feature

Cath lab concerns prompted by COVID-19

March 25, 2020
As more is learned about the COVID-19 pandemic, cardiology societies have issued advisories with steps to take in the cardiac catheterization…
In the JournalsPerspective

Coronavirus shows low risk for being spread through tears

March 25, 2020
SARS-CoV-2 is known to be transmitted via droplets, but infected patients are unlikely to spread the virus through tears, according to a study. …
Breaking News

Experts ‘troubled’ by Trump’s Easter timeline to lift COVID-19 restrictions

March 25, 2020
Experts said they were “troubled” by President Trump’s suggestion that the United States could lift pandemic-related restrictions…

Insulin manufacturers: Supplies stable, but ‘plan ahead’

March 25, 2020
The three U.S. manufacturers of insulin are reporting stable supplies of all diabetes medications as fears of drug shortages rise, though the…

APA poll shows high anxiety among Americans during COVID-19 pandemic

March 25, 2020
Nearly half of Americans are anxious about the possibility of getting COVID-19, and nearly 40% are anxious about dying or becoming seriously ill due…
In the Journals

Cardiac injury confers greater mortality in patients with COVID-19

March 25, 2020
Among patients with laboratory-confirmed COVID-19 in Wuhan, China, those with cardiac injury had a higher risk for in-hospital mortality than…

Aldeyra to screen ADX-629, reproxalap for COVID-19 treatment

March 25, 2020
Aldeyra Therapeutics plans to screen its reactive aldehyde species inhibitors for anti-inflammatory and antiviral activity in the treatment of…